PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cardiovascular Diseases

Pfizer Signs an Option and License Agreement with Voyager to Develop and Commercialize Gene Therapies for Neurologic and Cardiovascular Diseases

Pfizer Signs an Option and License Agreement with Voyager to Develop and Commercialize Gene Therapies for Neurologic and Cardiovas...

October 7, 2021

Bayer and One Drop Collaborate to Develop Digital Therapies Across Multiple Therapeutic Areas

Bayer and One Drop Collaborate to Develop Digital Therapies Across Multiple Therapeutic Areas

August 24, 2020

AstraZeneca Signs an Agreement with Gatehouse Bio to Identify New Therapies Targeting Respiratory and Cardiovascular Diseases

AstraZeneca Signs an Agreement with Gatehouse Bio to Identify New Therapies Targeting Respiratory and Cardiovascular Diseases

December 5, 2019

Baxter's Eptifibatide Receives the US FDA's Approval for Cardiovascular Diseases

Baxter's Eptifibatide Receives the US FDA's Approval for Cardiovascular Diseases

March 7, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us